Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04141241
What this trial is testing

Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular

Who this might be right for
Type 2 Diabetes Mellitus With Circulatory Complciation
Bota Bio Co., Ltd. 82
Large-scale testing (Phase 3)Study completedNCT02244879
What this trial is testing

Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes MellitusInflammationInsulin Resistance+1 more
University of Turin, Italy 192
Not applicableUnknownNCT03495362
What this trial is testing

The Effect of Insoluble Yeast Beta-glucan Intake on Pre-diabetic Patients

Who this might be right for
Pre-diabetic
Huazhong University of Science and Technology 52
Testing effectiveness (Phase 2)Study completedNCT04507061
What this trial is testing

Study on the Safety of the Drug Runcaciguat and How Well it Works When Given at the Highest Dose as Tolerated by Individual Patient Whose Kidneys Are Not Working Properly and Suffering at the Same Time From High Blood Sugar and/or High Blood Pressure and a Disease of the Heart and the Blood Vessels.

Who this might be right for
Chronic Kidney Disease
Bayer 243
Large-scale testing (Phase 3)Ended earlyNCT00900146
What this trial is testing

Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 556
Testing effectiveness (Phase 2)Study completedNCT03179423
What this trial is testing

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years

Who this might be right for
Diabetes Mellitus Type 1
GeNeuro Australia PTY Ltd 64
Large-scale testing (Phase 3)Study completedNCT01076088
What this trial is testing

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 744
Testing effectiveness (Phase 2)Study completedNCT00421733
What this trial is testing

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
Abbott 281
Large-scale testing (Phase 3)Study completedNCT06066515
What this trial is testing

Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

Who this might be right for
Obesity
Boehringer Ingelheim 726
Early research (Phase 1)Study completedNCT01497574
What this trial is testing

Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06813274
What this trial is testing

Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling

Who this might be right for
Diabetes MellitusDiabetic RetinopathyCognitive Impairment+1 more
Hejiang Ye 160
Post-approval studies (Phase 4)Study completedNCT03770052
What this trial is testing

Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie

Who this might be right for
Type 2 Diabetes MellitusInadequate Glucose Control
Pusan National University Hospital 159
Early research (Phase 1)Study completedNCT02077452
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Hua Medicine Limited 53
Large-scale testing (Phase 3)Study completedNCT01879917
What this trial is testing

Liraglutide in Newly Onset Type 1 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 1
Hvidovre University Hospital 65
Testing effectiveness (Phase 2)Ended earlyNCT04524949
What this trial is testing

IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

Who this might be right for
Diabetes Mellitus, Type 1
Imcyse SA 110
Large-scale testing (Phase 3)Study completedNCT01778049
What this trial is testing

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 708
Testing effectiveness (Phase 2)Study completedNCT01113515
What this trial is testing

Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Novalead Pharma Private Limited 44
Large-scale testing (Phase 3)Active Not RecruitingNCT06290349
What this trial is testing

Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
Dong-A ST Co., Ltd. 174
Large-scale testing (Phase 3)UnknownNCT05102149
What this trial is testing

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 672
Large-scale testing (Phase 3)Study completedNCT02897349
What this trial is testing

Linagliptin Add-on to Insulin Background Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 206
Next Page